Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable LRR domain binding activity. Acts upstream of or within MyD88-dependent toll-like receptor 4 signaling pathway; MyD88-independent toll-like receptor signaling pathway; and positive regulation of tumor necrosis factor production. Is expressed in 1st branchial arch mandibular component mesenchyme; craniocervical region bone; and facial prominence. Orthologous to human LRRFIP2 (LRR binding FLII interacting protein 2).